A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
for HPV-Related Cervical Carcinoma
4 locations incl. Orlando
Sponsor: Theravectys S.A.
Sex: All·Age: 18+
Code: NCT06319963·Phase 1, Phase 2·Recruiting·Listed Mar 2024